Q5105 Injection retacrit esrd on dialysi
Also known as: Retacrit injection ESRD, epoetin alfa-epbx, EPO
Injection of Retacrit, epoetin alfa-epbx biosimilar for end-stage renal disease patients on dialysis, per unit.
In Plain Language
red blood cell stimulator; anemia treatment
Clinical Context
Used for anemia management in end-stage renal disease patients undergoing dialysis therapy.
RVU Information
CPT Q5105 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5105?
CPT Q5105 (Injection retacrit esrd on dialysi) is a Q Codes code. Injection of Retacrit, epoetin alfa-epbx biosimilar for end-stage renal disease patients on dialysis, per unit.
Is Q5105 covered by insurance?
Q5105 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for anemia management in end-stage renal disease patients undergoing dialysis therapy.
When is CPT Q5105 used?
Used for anemia management in end-stage renal disease patients undergoing dialysis therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.